Skip to main content
. 2022 Sep 3;26(20):5150–5164. doi: 10.1111/jcmm.17540

FIGURE 1.

FIGURE 1

SNORA70E expression in ovarian tissues and cancer cell lines. SNORA70E is an unfavourable prognostic factor for ovarian cancer (A). SNORA70E expression was significantly higher in epithelial ovarian cancer tissues than in borderline tumour tissues, benign tissues, and normal ovaries (B). And SNORA70E expression was higher in stages II–IV than in stage I (C); in the moderately and poorly pathological classified disease than in pathologically well‐classified disease (D); in ovarian serous adenocarcinoma than in the other types (E). Data is calculated and shown as the mean ± SD (error bars). *p < 0.05. (Mann–Whitney U test). SNORA70E expression in ovarian cancer cell lines (F). SNORA70E overexpression induced SNORA70E expression level in CAOV3 cells (G), SNORA70E downregulation by ASO reduced SNORA70E expression level in OVCAR3 cells (H). Data is calculated and shown as the mean ± SD (error bars) from three independent repeats. *p < 0.05. (Student's t‐test).